Asset Details
Do you wish to reserve the book?
Polynucleotides Enhance Skin Barrier Function and Reduce Inflammation in a 2,4‐Dinitrochlorobenzene‐Induced Mouse Model of Atopic Dermatitis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Polynucleotides Enhance Skin Barrier Function and Reduce Inflammation in a 2,4‐Dinitrochlorobenzene‐Induced Mouse Model of Atopic Dermatitis
Do you wish to request the book?
Polynucleotides Enhance Skin Barrier Function and Reduce Inflammation in a 2,4‐Dinitrochlorobenzene‐Induced Mouse Model of Atopic Dermatitis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Polynucleotides Enhance Skin Barrier Function and Reduce Inflammation in a 2,4‐Dinitrochlorobenzene‐Induced Mouse Model of Atopic Dermatitis
2025
Overview
Background Atopic dermatitis (AD) is a chronic inflammatory dermatological disorder characterized by skin barrier dysfunction, dry skin, pruritus, and aberrant immune responses to external stimuli. Although polynucleotides (PNs) have anti‐inflammatory properties, their effect on AD remains unexplored. Materials and Methods This study investigated the effects of PNs on a 2,4‐dinitrochlorobenzene (DNCB)‐induced AD mouse model. The effects were evaluated by the dermatitis severity score (DSS), the spleen index, the serum immunoglobulin E (IgE) concentration, trans‐epidermal water loss (TEWL), histological findings, and the expression levels of cytokine mRNA and filaggrin protein in skin tissue. Results Topical application of PNs significantly reduced the DSS, the spleen index, the serum IgE concentration, and TEWL compared with the control. Additionally, histopathological analysis showed that PNs reduced epidermal and dermal thickness, the mast cell count, collagen deposition, and eosinophil infiltration in the dermis. Moreover, PNs significantly downregulated the expression of key inflammatory cytokines, including interleukin (IL)‐4, IL‐5, IL‐13, IL‐25, IL‐33, and thymic stromal lymphopoietin (TSLP), in affected skin tissue. Immunohistochemical (IHC) staining and Western blot revealed that PNs inhibited DNCB‐induced suppression of filaggrin. A combination of hyaluronic acid (HA) and PNs showed enhanced efficacy compared with PNs alone, particularly for reducing the serum IgE concentration and TEWL and increasing filaggrin expression. Conclusion These results suggest that PNs are potential candidates to treat AD because they possess anti‐inflammatory properties and improve skin barrier function.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc
Subject
/ Animals
/ Dermatitis, Atopic - chemically induced
/ Dermatitis, Atopic - drug therapy
/ Dermatitis, Atopic - pathology
/ Dermis
/ Female
/ Intermediate Filament Proteins - metabolism
/ Male
/ Mice
/ mRNA
/ Original
/ Polynucleotides - administration & dosage
/ Polynucleotides - pharmacology
/ Polynucleotides - therapeutic use
/ Pruritus
/ Skin
/ Spleen
/ Thymic stromal lymphopoietin
/ Thymus
